Squamous cell carcinoma
Reviewers: Komal Arora, M.D., (see Reviewers page)
Revised: 21 April 2012, last major update March 2012
Copyright: (c) 2003-2012, PathologyOutlines.com, Inc.
● Extremely rare; incidence is <0.6% of all prostate cancers
● Criteria for diagnosis of primary squamous cell carcinoma of the prostate:
● (i) The presence of unequivocal features of malignancy
● (ii) The presence of definitive squamous differentiation
● (iii) Lack of a conventional carcinoma component
● (iv) No prior treatment with radiation or hormones
● (v) No squamous cell carcinoma elsewhere (Mod Pathol 2004;17:316)
● Originates from the periurethral glands or prostatic acinar basal cells
● Occurs de novo or after estrogen therapy, flutamine therapy, radiation seed implantation
● Poor survival
● Have normal serum PSA and PSAP levels
● Tumors develop osteolytic metastases, donít respond to hormone therapy
● Donít develop increased PSA with metastases
● Pure tumors exhibit infiltrating nests, strands, and sheets of polygonal cells with nuclear atypia
● Squamous differentiation is manifested as individual cell keratinization, intercellular bridges or keratin pearl formation
● PSA, PSAP
End of Prostate > Other carcinomas > Squamous cell carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).